Logo
x

Search

Subscribe Now

extends

The US FDA Extends Review Period of Olumiant's sNDA to Treat Moderate to Severe Atopic Dermatitis

The US FDA Extends Review Period of Olumiant's sNDA to Treat Moderate to Severe Atopic Dermatitis

  • April 7, 2021
Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan

Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan

  • December 14, 2020
The US FDA Extends Review of sBLA of Ofatumumab (OMB157) for Patients with Relapsing Multiple Sclerosis

The US FDA Extends Review of sBLA of Ofatumumab (OMB157) for Patients with Relapsing Multiple Sclerosis

  • June 3, 2020
Pfizer Extends its Research and License Agreement with BioInvent to Develop Ab Targeting Tumor-Associated Myeloid Cells

Pfizer Extends its Research and License Agreement with BioInvent to Develop Ab Targeting Tumor-Associated Myeloid Cells

  • December 26, 2019
Janssen Extends its Research and Licensing Agreement with SVI to Develop Therapies for Alzheimer's Disease

Janssen Extends its Research and Licensing Agreement with SVI to Develop Therapies for Alzheimer's Disease

  • August 30, 2019
Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

Cantargia Extends Licensing Agreement with BioWa for its POTELLIGENT Technology

  • August 23, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.